Publications
Specialty
Search
Podiatry Today, Wound Care
10/03/2024
Expanding on his SAWC Fall poster, this author discusses why cognitive dysfunction can cause complications in patients with DFUs, and how DPMs can help.
EP Lab Digest
10/03/2024
Drs Gul and Sertdemir present a case of a patient with ischemic cardiomyopathy who underwent left bundle branch area pacing-optimized cardiac resynchronization therapy upgrade due to complete heart block and high burden of ventricular pacing.
Foot and Ankle Surgery Institute, Wounds
10/03/2024
This surgeon discusses his SAWC Fall poster on using transforming dressing powder in combat wounds.
Podiatry Today, Wounds
10/03/2024
This author discusses her SAWC Fall poster on the value of podiatric referral, its ideal timing, and educating patients via the teach-back method.
Gastroenterology
10/03/2024
Host Brian Lacy, MD, discusses the diagnosis, treatment, and prevention of diverticular disease with Dr Anne Peery in the latest episode of Gut Check.
Advances in Inflammatory Bowel Disease Network
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Wounds, Wound Care
10/03/2024
In this video interview, Emily Greenstein, APRN, CNP, CWON, FACCWS, shares key insights from her poster, "Hard-to-Heal Wound Management: Real World Implementation of Community-Based Health Care Recommendations," presented at the Symposium on Advanced Wound Care (SAWC) Fall in Las Vegas, NV, in October 2024.
Wounds, Wound Care
10/03/2024
In this video interview, Linda T Miller, PT, DPT, CLT, CWT, shares key insights from her poster, "Healing Beyond Expectations: The Use of Innovative Moisture Management Dressings for Chronic Wounds in Home Care," presented at the Symposium on Advanced Wound Care (SAWC) Fall in Las Vegas, NV, in October 2024.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/03/2024
“We can show that a low level of the natural antibody to phosphorylcholine can be used as a risk marker for cardiovascular disease also in women, independent of previously known risk factors," said Dr. Johan Frostegård.
Oncology
10/03/2024
Do you know whether SHR-A1811 demonstrated promising antitumor activity among heavily pretreated patients with HER2-expressing or mutated advanced solid tumors? Take our quiz to find out!
Wounds, Wound Care
10/03/2024
High morbidity and multifocal disease are significant challenges to quality of life for patients with advanced hidradenitis suppurativa. In an effort to outline a treatment plan that addresses these concerns, Joshua Dickerson, MD, and Abigail E. Chaffin MD, FACS, CWSP, MAPWCA, have prepared a poster to be presented at the Symposium on Advanced Wound Care (SAWC) Fall.
Oncology
10/03/2024
Based on results from the CHECKMATE-77T trial, the FDA has approved nivolumab plus platinum-doublet chemotherapy followed by surgical resection and single-agent nivolumab for patients with non-small cell lung cancer with no known EGFR mutations or ALK rearrangements.
Integrated Healthcare Executive
10/03/2024
As COVID-19 cases decrease, research explores population immunity and vaccine effectiveness against severe disease in the face of emerging variants, highlighting the importance of enhancing immune responses and patient outcomes.
EMSWorld
10/03/2024
Emergency department overcrowding, manifested by filled ER bays, overflowing waiting rooms, and more is widely reported in the US. However, many other developed countries face similar fallout from a lack of emergency capacity.
EP Lab Digest
10/03/2024
Catheter Precision, Inc, a company dedicated in the development and marketing of technologically advanced products for the cardiac electrophysiology market, today announced several updates for their VIVO non-invasive mapping system.
EP Lab Digest
10/03/2024
Study will assess the Company's Next-Generation device under Intracardiac Echocardiography (ICE) imaging for Left Atrial Appendage Occlusion (LAAO) procedures.
EP Lab Digest
10/03/2024
Approval provides new catalyst for AtriCure’s international growth
EP Lab Digest
10/03/2024
InCarda Therapeutics Press Release
SAN FRANCISCO -- InCarda Therapeutics, Inc.:
• Analysis of the results of the RESTORE-1 Phase 3 trial following its premature termination demonstrated statistically significant cardioversion of PAF with orally inhaled flecainide, providing compelling rationale for the continued development of FlecIH-103 in the target population of PAF patients.
— The RESTORE-1 trial was stopped prematurely due to lower-than-expected efficacy and plasma flecainide levels during a blinded review of the data
EP Lab Digest
10/03/2024
Thryv Therapeutics Press Release
IO Learning
10/03/2024
At the 2024 CIO Meeting, Yolanda Bryce, MD, discusses the use of cryoablation for patients with breast cancer.
Reimbursement Library From A to Z
Subscribe and never miss an article!
Today's Wound Clinic Newsletter
